Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer02:18

Cancer

53.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
What is Cancer?02:12

What is Cancer?

13.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
13.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

586
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
586
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classic Hodgkin Lymphoma Beyond the Lymph Node: A Systemic Immunobiological Paradigm.

Cancers·2026
Same author

Hodgkin Lymphoma Classification-From Historical Concepts to Current Refinements.

Cancers·2025
Same author

Immune Checkpoint Molecules in Hodgkin Lymphoma and Other Hematological Malignancies.

Cancers·2025
Same author

Lymphoproliferations in People Living with HIV: Oncogenic Pathways, Diagnostic Challenges, and New Therapeutic Opportunities.

Cancers·2025
Same author

Immune Deficiency/Dysregulation-Associated EBV-Positive Classic Hodgkin Lymphoma.

Cancers·2025
Same author

Pathobiological Features and Therapeutic Opportunities Linked to TNF Family Member Expression in Classic Hodgkin Lymphoma.

Cancers·2024

Related Experiment Video

Updated: Dec 23, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.0K

Cancer Classification at the Crossroads.

Antonino Carbone1

  • 1Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Via F. Gallini 2, I-33081 Aviano, Italy.

Cancers
|April 25, 2020
PubMed
Summary
This summary is machine-generated.

Cancer classifications are evolving beyond traditional methods. Molecular genomics is increasingly refining tumor diagnosis and guiding treatment decisions, even independent of cancer type.

Keywords:
cancercancer diagnosiscancer genomicscancer managementclassifications

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.5K

Related Experiment Videos

Last Updated: Dec 23, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.5K

Area of Science:

  • Oncology
  • Genomics
  • Cancer Research

Background:

  • Internationally accepted cancer classifications by WHO and UICC historically rely on histotype, site, grade, and spread.
  • These classifications form the basis for cancer diagnosis and management strategies.
  • Since 2000, classifications increasingly incorporate biologic and molecular-genetic features.

Purpose of the Study:

  • To discuss the evolving landscape of cancer classification in the era of cancer genomics.
  • To highlight the impact of molecular-genetic profiling on refining tumor classification and treatment selection.

Main Methods:

  • Review of World Health Organization (WHO) and Union for International Cancer Control (UICC) classification systems.
  • Analysis of the integration of molecular-genetic features into cancer diagnosis.
  • Discussion of the implications of cancer genomics for future classifications.

Main Results:

  • Molecular-genetic profiling refines existing tumor classifications.
  • For some cancers, molecular profiling can dictate treatment irrespective of histotype.
  • The impact of genomics on cancer diagnosis and treatment is rapidly increasing.

Conclusions:

  • Cancer classification is transitioning towards a more molecular-driven approach.
  • Genomic advancements are revolutionizing personalized cancer care.
  • Future cancer classifications will heavily integrate molecular and genetic data.